<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Thu, 29 May 2025 11:38:46 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Geriatric CDS Tool Boosts Safe Prescribing in the ED</title><link>https://www.medscape.com/viewarticle/geriatric-clinical-decision-support-tool-boosts-safe-2025a1000e67?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>The use of a clinical decision support system significantly improves adherence to safer prescribing practices for older adults in the ED. Medscape Med...</description><pubDate>Thu, 29 May 2025 13:36:03 GMT</pubDate></item><item><title>Physicians Weigh in on Coffee Enema Trends</title><link>https://www.medscape.com/viewarticle/physicians-weigh-coffee-enema-trends-2025a1000dz2?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Medical pros revisit the 150-year history of coffee enemas to weigh their potential benefits and hidden dangers. Medscape Medical News</description><pubDate>Thu, 29 May 2025 13:14:15 GMT</pubDate></item><item><title>Defying Grim Prognosis to Celebrate a 20th ‘Cancerversary’</title><link>https://www.medscape.com/viewarticle/defying-grim-prognosis-celebrate-20th-cancerversary-2025a1000e5m?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his condition have enabled him t...</description><pubDate>Thu, 29 May 2025 13:04:32 GMT</pubDate></item><item><title>Spesolimab Provides Sustained Improvement of GPP and QOL</title><link>https://www.medscape.com/viewarticle/spesolimab-provides-sustained-improvement-gpp-symptoms-and-2025a1000e5e?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>At least twice as many patients on the approved spesolimab dose maintain improvement in skin symptoms and quality of life through 48 weeks compared wi...</description><pubDate>Thu, 29 May 2025 13:00:32 GMT</pubDate></item><item><title>Telemonitoring Boosts Glycaemic Control in T2D</title><link>https://www.medscape.com/viewarticle/telemonitoring-boosts-glycaemic-control-t2d-2025a1000da6?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Telemonitoring with continuous glucose monitoring and insulin pens outperforms standard-of-care practices for improving glycaemic control in patients ...</description><pubDate>Thu, 29 May 2025 13:00:00 GMT</pubDate></item></channel></rss>